Cohance Lifesciences Limited (NSE:COHANCE)

Cohance Lifesciences Revenue

Cohance Lifesciences had revenue of 4.22B INR in the quarter ending June 30, 2026, a decrease of -23.13%. This brings the company's revenue in the last twelve months to 21.42B, up 70.12% year-over-year. In the fiscal year ending March 31, 2026, Cohance Lifesciences had annual revenue of 22.69B, down -13.03%.

• Revenue (ttm): 21.42B
• Revenue Growth: +70.12%
• P/S Ratio: 8.27
• Revenue / Employee: 17.67M
• Employees: 1,212
• Market Cap: 177.13B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	22.69B	-3.40B	-13.03%
Mar 31, 2025	26.09B	15.57B	148.11%
Mar 31, 2024	10.51B	-2.89B	-21.56%
Mar 31, 2023	13.40B	201.07M	1.52%
Mar 31, 2022	13.20B	3.11B	30.75%

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 21, 2026

Data Sources Report a data error